Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance

Background. Incident and prevalent (I&P) rates in dialysis end-stage renal disease (ESRD) patients in Taiwan increased rapidly following the launch of National Health Insurance (NHI) in 1995. Our aim was to explore the impact of NHI on the status and trends of ESRD epidemiology in Taiwan. Method...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2008-12, Vol.23 (12), p.3977-3982
Hauptverfasser: Yang, Wu-Chang, Hwang, Shang-Jyh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3982
container_issue 12
container_start_page 3977
container_title Nephrology, dialysis, transplantation
container_volume 23
creator Yang, Wu-Chang
Hwang, Shang-Jyh
description Background. Incident and prevalent (I&P) rates in dialysis end-stage renal disease (ESRD) patients in Taiwan increased rapidly following the launch of National Health Insurance (NHI) in 1995. Our aim was to explore the impact of NHI on the status and trends of ESRD epidemiology in Taiwan. Methods. This study was conducted using retrospective cohort analysis of data collected from the Taiwan national dialysis registry. Results. From 1990 to 2001, I&P rates of ESRD patients increased 2.6 times from 126 to 331 per million populations (pmp) and 3.46 times from 382 to 1322 pmp, respectively. Increasing ESRD was seen in patients who were middle-aged, elderly and who had diabetic nephropathy as their primary renal disease. The mean age of I&P patients increased by 7.2 years and 7.1 years, respectively. All of these parameters increased markedly in 1995, the year of NHI implementation. First-year mortality decreased to 7.8 per 1000 patient-months in 1994, and then increased to 18.0 in 2001. The cumulative survival rate of the elderly subgroup (age >65) in the incident 1990–1994 cohort was greater than in the 1995–1999 cohort. These data indicated that NHI implementation significantly influenced the inflow and the mortality of ESRD patients. Conclusion. In addition to presenting ESRD epidemiology in Taiwan, this study demonstrated that NHI implementation stimulated the growth of treated ESRD populations. Preventive plans mounted against chronic kidney diseases will be essential to reduce the growth of ESRD patient numbers and consequent economic burdens.
doi_str_mv 10.1093/ndt/gfn406
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69823382</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ndt/gfn406</oup_id><sourcerecordid>69823382</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-c1ea85785d51db06c6d2a600b913462b96488c120996474aec50777c6404b2543</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi0EosvChQdAFhIcEKFjJ3GS3tCK0koFDhRRcbEmjtN1SexgO8A-By-Mo121EgcOlkcz3_zj8U_IUwZvGDT5se3i8XVvCxD3yIoVAjKe1-V9skpFlkEJzRF5FMINADS8qh6SI1YLXudCrMifc6tMp63Sr-nk9U8clpii7ejofMTBxB2NXtsuUNfTzuCwCybQlMhCxGtNUw2HVAgag6bG0ks0v9DS3ruRsqYBGh3lAOyExm0CxglVXLQsRuOW3q3GIW5Ta5g9pumPyYMeh6CfHO41-XL67nJzll18en--eXuRqaIQMVNMY11WddmVrGtBKNFxFABtw_JC8LYRRV0rxqFJUVWgViVUVaVEAUXLyyJfk5d73cm7H7MOUY4mKD0MaLWbgxRNzfM8nTV5_g9442afnh4kZzUTVZlDgl7tIeVdCF73cvJmRL-TDOTik0w-yb1PCX52UJzbUXd36MGYBLw4ABgUDv3yMSbccmmptBLwO87N0_8HZnvOhKh_35Lov0tR5VUpz66-yQ-bz-JjfXUqv-Z_AUoItjs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218167530</pqid></control><display><type>article</type><title>Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Yang, Wu-Chang ; Hwang, Shang-Jyh</creator><creatorcontrib>Yang, Wu-Chang ; Hwang, Shang-Jyh ; Taiwan Society of Nephrology</creatorcontrib><description>Background. Incident and prevalent (I&amp;P) rates in dialysis end-stage renal disease (ESRD) patients in Taiwan increased rapidly following the launch of National Health Insurance (NHI) in 1995. Our aim was to explore the impact of NHI on the status and trends of ESRD epidemiology in Taiwan. Methods. This study was conducted using retrospective cohort analysis of data collected from the Taiwan national dialysis registry. Results. From 1990 to 2001, I&amp;P rates of ESRD patients increased 2.6 times from 126 to 331 per million populations (pmp) and 3.46 times from 382 to 1322 pmp, respectively. Increasing ESRD was seen in patients who were middle-aged, elderly and who had diabetic nephropathy as their primary renal disease. The mean age of I&amp;P patients increased by 7.2 years and 7.1 years, respectively. All of these parameters increased markedly in 1995, the year of NHI implementation. First-year mortality decreased to 7.8 per 1000 patient-months in 1994, and then increased to 18.0 in 2001. The cumulative survival rate of the elderly subgroup (age &gt;65) in the incident 1990–1994 cohort was greater than in the 1995–1999 cohort. These data indicated that NHI implementation significantly influenced the inflow and the mortality of ESRD patients. Conclusion. In addition to presenting ESRD epidemiology in Taiwan, this study demonstrated that NHI implementation stimulated the growth of treated ESRD populations. Preventive plans mounted against chronic kidney diseases will be essential to reduce the growth of ESRD patient numbers and consequent economic burdens.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfn406</identifier><identifier>PMID: 18628366</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cohort Studies ; dialysis ; Emergency and intensive care: renal failure. Dialysis management ; Female ; health insurance ; Humans ; incidence ; Intensive care medicine ; Kidney Failure, Chronic - economics ; Kidney Failure, Chronic - epidemiology ; Kidney Failure, Chronic - mortality ; Kidney Failure, Chronic - therapy ; Male ; Medical sciences ; Middle Aged ; mortality ; National Health Programs ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; prevalence ; Registries ; Renal Dialysis - economics ; Renal failure ; Retrospective Studies ; Survival Rate ; Taiwan - epidemiology</subject><ispartof>Nephrology, dialysis, transplantation, 2008-12, Vol.23 (12), p.3977-3982</ispartof><rights>Oxford University Press © The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2008</rights><rights>2009 INIST-CNRS</rights><rights>The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-c1ea85785d51db06c6d2a600b913462b96488c120996474aec50777c6404b2543</citedby><cites>FETCH-LOGICAL-c446t-c1ea85785d51db06c6d2a600b913462b96488c120996474aec50777c6404b2543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20947402$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18628366$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Wu-Chang</creatorcontrib><creatorcontrib>Hwang, Shang-Jyh</creatorcontrib><creatorcontrib>Taiwan Society of Nephrology</creatorcontrib><title>Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol Dial Transplant</addtitle><addtitle>Nephrol Dial Transplant</addtitle><description>Background. Incident and prevalent (I&amp;P) rates in dialysis end-stage renal disease (ESRD) patients in Taiwan increased rapidly following the launch of National Health Insurance (NHI) in 1995. Our aim was to explore the impact of NHI on the status and trends of ESRD epidemiology in Taiwan. Methods. This study was conducted using retrospective cohort analysis of data collected from the Taiwan national dialysis registry. Results. From 1990 to 2001, I&amp;P rates of ESRD patients increased 2.6 times from 126 to 331 per million populations (pmp) and 3.46 times from 382 to 1322 pmp, respectively. Increasing ESRD was seen in patients who were middle-aged, elderly and who had diabetic nephropathy as their primary renal disease. The mean age of I&amp;P patients increased by 7.2 years and 7.1 years, respectively. All of these parameters increased markedly in 1995, the year of NHI implementation. First-year mortality decreased to 7.8 per 1000 patient-months in 1994, and then increased to 18.0 in 2001. The cumulative survival rate of the elderly subgroup (age &gt;65) in the incident 1990–1994 cohort was greater than in the 1995–1999 cohort. These data indicated that NHI implementation significantly influenced the inflow and the mortality of ESRD patients. Conclusion. In addition to presenting ESRD epidemiology in Taiwan, this study demonstrated that NHI implementation stimulated the growth of treated ESRD populations. Preventive plans mounted against chronic kidney diseases will be essential to reduce the growth of ESRD patient numbers and consequent economic burdens.</description><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>dialysis</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>health insurance</subject><subject>Humans</subject><subject>incidence</subject><subject>Intensive care medicine</subject><subject>Kidney Failure, Chronic - economics</subject><subject>Kidney Failure, Chronic - epidemiology</subject><subject>Kidney Failure, Chronic - mortality</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>mortality</subject><subject>National Health Programs</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>prevalence</subject><subject>Registries</subject><subject>Renal Dialysis - economics</subject><subject>Renal failure</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><subject>Taiwan - epidemiology</subject><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAQhi0EosvChQdAFhIcEKFjJ3GS3tCK0koFDhRRcbEmjtN1SexgO8A-By-Mo121EgcOlkcz3_zj8U_IUwZvGDT5se3i8XVvCxD3yIoVAjKe1-V9skpFlkEJzRF5FMINADS8qh6SI1YLXudCrMifc6tMp63Sr-nk9U8clpii7ejofMTBxB2NXtsuUNfTzuCwCybQlMhCxGtNUw2HVAgag6bG0ks0v9DS3ruRsqYBGh3lAOyExm0CxglVXLQsRuOW3q3GIW5Ta5g9pumPyYMeh6CfHO41-XL67nJzll18en--eXuRqaIQMVNMY11WddmVrGtBKNFxFABtw_JC8LYRRV0rxqFJUVWgViVUVaVEAUXLyyJfk5d73cm7H7MOUY4mKD0MaLWbgxRNzfM8nTV5_g9442afnh4kZzUTVZlDgl7tIeVdCF73cvJmRL-TDOTik0w-yb1PCX52UJzbUXd36MGYBLw4ABgUDv3yMSbccmmptBLwO87N0_8HZnvOhKh_35Lov0tR5VUpz66-yQ-bz-JjfXUqv-Z_AUoItjs</recordid><startdate>20081201</startdate><enddate>20081201</enddate><creator>Yang, Wu-Chang</creator><creator>Hwang, Shang-Jyh</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20081201</creationdate><title>Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance</title><author>Yang, Wu-Chang ; Hwang, Shang-Jyh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-c1ea85785d51db06c6d2a600b913462b96488c120996474aec50777c6404b2543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>dialysis</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>health insurance</topic><topic>Humans</topic><topic>incidence</topic><topic>Intensive care medicine</topic><topic>Kidney Failure, Chronic - economics</topic><topic>Kidney Failure, Chronic - epidemiology</topic><topic>Kidney Failure, Chronic - mortality</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>mortality</topic><topic>National Health Programs</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>prevalence</topic><topic>Registries</topic><topic>Renal Dialysis - economics</topic><topic>Renal failure</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><topic>Taiwan - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Wu-Chang</creatorcontrib><creatorcontrib>Hwang, Shang-Jyh</creatorcontrib><creatorcontrib>Taiwan Society of Nephrology</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Wu-Chang</au><au>Hwang, Shang-Jyh</au><aucorp>Taiwan Society of Nephrology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><stitle>Nephrol Dial Transplant</stitle><addtitle>Nephrol Dial Transplant</addtitle><date>2008-12-01</date><risdate>2008</risdate><volume>23</volume><issue>12</issue><spage>3977</spage><epage>3982</epage><pages>3977-3982</pages><issn>0931-0509</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>Background. Incident and prevalent (I&amp;P) rates in dialysis end-stage renal disease (ESRD) patients in Taiwan increased rapidly following the launch of National Health Insurance (NHI) in 1995. Our aim was to explore the impact of NHI on the status and trends of ESRD epidemiology in Taiwan. Methods. This study was conducted using retrospective cohort analysis of data collected from the Taiwan national dialysis registry. Results. From 1990 to 2001, I&amp;P rates of ESRD patients increased 2.6 times from 126 to 331 per million populations (pmp) and 3.46 times from 382 to 1322 pmp, respectively. Increasing ESRD was seen in patients who were middle-aged, elderly and who had diabetic nephropathy as their primary renal disease. The mean age of I&amp;P patients increased by 7.2 years and 7.1 years, respectively. All of these parameters increased markedly in 1995, the year of NHI implementation. First-year mortality decreased to 7.8 per 1000 patient-months in 1994, and then increased to 18.0 in 2001. The cumulative survival rate of the elderly subgroup (age &gt;65) in the incident 1990–1994 cohort was greater than in the 1995–1999 cohort. These data indicated that NHI implementation significantly influenced the inflow and the mortality of ESRD patients. Conclusion. In addition to presenting ESRD epidemiology in Taiwan, this study demonstrated that NHI implementation stimulated the growth of treated ESRD populations. Preventive plans mounted against chronic kidney diseases will be essential to reduce the growth of ESRD patient numbers and consequent economic burdens.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>18628366</pmid><doi>10.1093/ndt/gfn406</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0931-0509
ispartof Nephrology, dialysis, transplantation, 2008-12, Vol.23 (12), p.3977-3982
issn 0931-0509
1460-2385
language eng
recordid cdi_proquest_miscellaneous_69823382
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Cohort Studies
dialysis
Emergency and intensive care: renal failure. Dialysis management
Female
health insurance
Humans
incidence
Intensive care medicine
Kidney Failure, Chronic - economics
Kidney Failure, Chronic - epidemiology
Kidney Failure, Chronic - mortality
Kidney Failure, Chronic - therapy
Male
Medical sciences
Middle Aged
mortality
National Health Programs
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
prevalence
Registries
Renal Dialysis - economics
Renal failure
Retrospective Studies
Survival Rate
Taiwan - epidemiology
title Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T21%3A43%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence,%20prevalence%20and%20mortality%20trends%20of%20dialysis%20end-stage%20renal%20disease%20in%20Taiwan%20from%201990%20to%202001:%20the%20impact%20of%20national%20health%20insurance&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Yang,%20Wu-Chang&rft.aucorp=Taiwan%20Society%20of%20Nephrology&rft.date=2008-12-01&rft.volume=23&rft.issue=12&rft.spage=3977&rft.epage=3982&rft.pages=3977-3982&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfn406&rft_dat=%3Cproquest_cross%3E69823382%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218167530&rft_id=info:pmid/18628366&rft_oup_id=10.1093/ndt/gfn406&rfr_iscdi=true